A recent BMJ study has shed light on what happens when patients stop taking GLP-1 medications like semaglutide and tirzepatide. The findings are important for anyone considering these treatments.
Key Findings:
The study followed patients who discontinued GLP-1 therapy and found:
Most patients regained a significant portion of lost weight within 12-24 months
Metabolic improvements (blood sugar, cholesterol) also reversed in many cases
Patients who maintained lifestyle changes fared better than those who didn’t
What This Means For You:
GLP-1s are not a “cure” - They work while you’re taking them, similar to blood pressure medications
Lifestyle changes matter - Building sustainable habits during treatment can help maintain results
Long-term planning is essential - Discuss with your provider what your maintenance strategy looks like
Discussion Questions:
Are you planning to use GLP-1s long-term, or as a tool to kickstart weight loss?
What lifestyle changes have you made while on treatment?
Has your provider discussed a maintenance plan with you?
I’d love to hear your thoughts and experiences on this topic. This is an area where we can all learn from each other!
Need Support on Your GLP-1 Journey?
If you’re looking for professional guidance and quality GLP-1 medications, Easy Trim Clinic offers comprehensive telehealth consultations with ongoing support to help you maintain your results long-term.
2+ years on semaglutide here, now on maintenance dose. This topic is important and I wish more people talked about it.
My experience: I lost 70 lbs in the first year, then transitioned to a lower maintenance dose. I’ve kept off about 60 lbs over the past year. The key for me was:
Never completely stopped - just reduced dose
Built sustainable habits WHILE losing weight
Addressed the behavioral stuff with a therapist
The medication is a tool, not a magic solution. You still gotta put in the work on mindset and habits.
Healthcare worker here - wanted to add some scientific context to this discussion.
The STEP 4 trial actually studied this exact question. Participants who continued semaglutide maintained their weight loss, while those switched to placebo regained about 2/3 of their lost weight over 48 weeks.
However, and this is important - even with regain, the discontinuation group was still better off than baseline. So it’s not “all or nothing.”
The emerging consensus in the literature is that obesity should be treated as a chronic condition, similar to hypertension. You wouldn’t stop blood pressure medication because your BP normalized, right?
That said, working on lifestyle factors while ON medication seems to improve long-term outcomes. The medication creates a window of opportunity to build habits.
This study highlights why the “just take a peptide and lose weight” approach is short-sighted. The research clearly shows that lifestyle modifications DURING the research period are crucial for long-term outcomes.
Key takeaways from this data:
Metabolic adaptation is real - Your body adjusts to the new weight. Abruptly stopping creates a rebound environment.
Tapering protocols - Some researchers are exploring gradual dose reduction rather than cold-stopping. The data on this is still emerging but promising.
Behavioral changes - Those who established new eating patterns and exercise habits during their research period showed significantly less regain.
The bigger picture:
GLP-1 compounds appear to work best as a TOOL for establishing new baselines, not as a permanent solution. Think of them as training wheels - eventually you need to build the habits to maintain without them.
For researchers planning ahead: Start documenting your lifestyle changes NOW, not when you’re planning to stop. Future you will thank current you.
Anyone have experience with successful tapering protocols? Would love to see more data on this.
